<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04301674</url>
  </required_header>
  <id_info>
    <org_study_id>UO1</org_study_id>
    <nct_id>NCT04301674</nct_id>
  </id_info>
  <brief_title>Metabolomics in Occupational Asthma</brief_title>
  <official_title>Pilot Study of Metabolomics in Occupational Asthma</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Oslo University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Owlstone Medical Ltd, Cambridge, UK)</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Oslo University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The project aims to increase the diagnostic accuracy in occupational asthma (OA), with
      emphasis on Irritant Induced Asthma (IIA). Currently, most patients are evaluated in
      occupational medicine by comparing the exposure and symptom characteristics with
      epidemiological data. Biological markers may be present in AA, but presently not in IIA. The
      majority of cases evaluated are considered as possible IIA, i.e. low-dose multiple exposures.
      VOC features will be analyzed with the Breath Biopsy® and TD-GS-MS (Owlstone Medical Ltd,
      UK).
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">March 17, 2020</start_date>
  <completion_date type="Anticipated">December 31, 2021</completion_date>
  <primary_completion_date type="Anticipated">March 31, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Discovery of VOC Biomarkers in Asthma</measure>
    <time_frame>Baseline</time_frame>
    <description>To evaluate the sensitivity, specificity, positive and negative predictive value of VOC biomarkers in exhaled breath samples to identify asthma.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Discovery of VOC Biomarkers in Occupational Irritant Asthma</measure>
    <time_frame>Baseline</time_frame>
    <description>To evaluate the sensitivity, specificity, positive and negative predictive value of VOC biomarkers in exhaled breath samples to identify irritant asthma after occupational exposures.</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Asthma, Occupational</condition>
  <arm_group>
    <arm_group_label>Occupational Asthma</arm_group_label>
    <description>Patients refered for assesment of occupational asthma</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Respiratory Healthy Control</arm_group_label>
    <description>Employees at Oslo University Hospital</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Breath Biopsy</intervention_name>
    <description>ReCIVA breath sampler (Owlstone Medical, Cambridge, UK)</description>
    <arm_group_label>Occupational Asthma</arm_group_label>
    <arm_group_label>Respiratory Healthy Control</arm_group_label>
  </intervention>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Volatile Organic Compounds (VOC) in exhaled air
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with occupational asthma, referred to the Unit of Environmental and Occupational
        medicine OUS for evaluation of OA.and healthy volunteers
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Asthma diagnosis established by lung specialist,

          -  Capable of informed consent

        Exclusion Criteria:

          -  Skin allergy towards plastics or rubber.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Bato Hammarstrøm, MD/PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Oslo University Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Bato Hammarström, MD/PhD</last_name>
    <phone>+47 230 16667</phone>
    <email>bato.hammarstrom@ous-hf.no</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Camilla Lund Sørass, MD/PhD</last_name>
    <phone>+47 221 17938</phone>
    <email>uxamlu@ous-hf.no</email>
  </overall_contact_backup>
  <verification_date>March 2020</verification_date>
  <study_first_submitted>March 4, 2020</study_first_submitted>
  <study_first_submitted_qc>March 5, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">March 10, 2020</study_first_posted>
  <last_update_submitted>March 5, 2020</last_update_submitted>
  <last_update_submitted_qc>March 5, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">March 10, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Oslo University Hospital</investigator_affiliation>
    <investigator_full_name>Bato Hammarstrøm</investigator_full_name>
    <investigator_title>Senior consultant/Research group leader</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Asthma</mesh_term>
    <mesh_term>Asthma, Occupational</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

